Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Pugazhendhi Vijayaraman

EP · Geisinger

View

Dr. Robert Schaller

EP · HUP

View

Dr. Felix Yang

EP · NYU Langone

View

Dr. Gregory Marcus

EP · UCSF

View

Dr. Miguel Leal

EP · Emory University Hospital

View

Dr. Chirag Barbhaiya

EP · NYU

View

Dr. William Sauer

EP · BWH

View

Dr. Dorairaj Prabhakaran

General Cardiology

View

Dr. Trey Woods

General Cardiology · Emory Healthcare

View

Dr. Brahmajee Nallamothu

Interventional Cardiology · UMHS

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Arrhythmia Research at a Tipping Point: The Need for Disruptive Science and Technology.

    Jul 22, 2024DOI: 10.1161/circep.123.012720Journal ArticleAHA

    Written by: Paul J WangGlenn I FishmanLee EckhardtJoseph C WuMario DelmarMina K ChungKristen K PattonAndrea M RussoChristine M AlbertSanjiv M Narayan

    Find these authors on Roon

    PW
    Dr. Paul Wang
    EP · Stanford

    Conclusions

    We believe that cardiac arrhythmia research is facing a crisis. The sinking trend in the number of basic science investigators and grant applications may signal that the field has reached a critical juncture, a tipping point requiring a significant set of new initiatives. A stagnation in beneficial clinical outcomes from arrhythmia therapy suggests to us that re-orientation of the research and development portfolio is imperative. This will require devising innovative strategies to fund disruptive ideas from promising scientists and re-prioritizing funding to attract scientists from all disciplines to join the field. Our call to action resounds with a sense of urgency; the time to invigorate arrhythmia research with fresh perspectives, robust funding, and collective resolve is now.
    PWDr. Paul Wang

    Dr. Paul Wang

    Cardiology · Cardiac Electrophysiology
    Stanford Medicine
    paulwang